Literature DB >> 3655728

Animal models in Q fever: pathological responses of inbred mice to phase I Coxiella burnetii.

G H Scott1, J C Williams, E H Stephenson.   

Abstract

The susceptibility of inbred strains of mice to infection by phase I Coxiella burnetii, the aetiological agent of Q fever, was investigated by evaluating morbidity, mortality, antibody production and in vitro proliferative responses of splenic lymphocytes. Among the 47 strains of mice tested for morbidity and mortality to C. burnetii infection, 33 were resistant, 10 were of intermediate sensitivity, and four were sensitive. A/J mice exhibited the highest mortality, and surviving mice of this strain yielded high concentrations of viable rickettsiae from essentially all organs for more than 3 weeks after inoculation. However, A/J mice developed a protective immune response after vaccination with inactivated C. burnetii cells. Induction of gross pathological responses and antibody production were similar in sensitive mice (strain A/J) and resistant mice (strain C57BL/6J). The LD50 of phase I C. burnetii for A/J mice was about 1000-fold lower than that for the more resistant C57BL/6J mice. Mice of both strains developed antibody titres against phase I cells, phase II cells, and phase I lipopolysaccharide after the injection of one or more viable phase I organisms of C. burnetii; five or more rickettsiae caused splenomegaly that was almost proportional to the infecting dose. Suppression of in vitro proliferative responses of splenic lymphocytes to concanavalin A, a T-cell mitogen, was apparent after infection of sensitive A/J mice with as few as one to five phase I micro-organisms. However, suppression of proliferation of splenic lymphocytes from resistant C57BL/6J mice required 10(7) phase I C. burnetii.

Entities:  

Mesh:

Year:  1987        PMID: 3655728     DOI: 10.1099/00221287-133-3-691

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  27 in total

Review 1.  Animal models of Q fever (Coxiella burnetii).

Authors:  Kevin R Bewley
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

2.  Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.

Authors:  K E Russell-Lodrigue; G Q Zhang; D N McMurray; J E Samuel
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

3.  Specificity of Legionella pneumophila and Coxiella burnetii vacuoles and versatility of Legionella pneumophila revealed by coinfection.

Authors:  John-Demian Sauer; Jeffrey G Shannon; Dale Howe; Stanley F Hayes; Michele S Swanson; Robert A Heinzen
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.

Authors:  L F Fries; D M Waag; J C Williams
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever.

Authors:  K E Russell-Lodrigue; M Andoh; M W J Poels; H R Shive; B R Weeks; G Q Zhang; C Tersteeg; T Masegi; A Hotta; T Yamaguchi; H Fukushi; K Hirai; D N McMurray; J E Samuel
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

7.  Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta.

Authors:  Stefanie Kunz; Karin Oberle; Anna Sander; Christian Bogdan; Ulrike Schleicher
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

8.  SCID mouse model for lethal Q fever.

Authors:  Masako Andoh; Takashi Naganawa; Akitoyo Hotta; Tsuyoshi Yamaguchi; Hideto Fukushi; Toshiaki Masegi; Katsuya Hirai
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Monoclonal antibody based capture ELISA/ELIFA for detection of Coxiella burnetii in clinical specimens.

Authors:  D Thiele; M Karo; H Krauss
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

10.  Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.

Authors:  I H Norville; G J Hatch; K R Bewley; D J Atkinson; K A Hamblin; J D Blanchard; S J Armstrong; J K Pitman; E Rayner; G Hall; J Vipond; T P Atkins
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.